These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 26468002

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.
    Cybulsky M, Cook S, Kontsevaya AV, Vasiljev M, Leon DA.
    BMC Cardiovasc Disord; 2016 Jun 03; 16():122. PubMed ID: 27255373
    [Abstract] [Full Text] [Related]

  • 23. Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study.
    Czernichow S, Knol MJ, Fezeu L, Grobbee DE.
    Eur J Prev Cardiol; 2012 Jun 03; 19(3):484-9. PubMed ID: 21464100
    [Abstract] [Full Text] [Related]

  • 24. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB, Dy SM, Millman EA, Herbert R, Bass EB, Wu A.
    Clin Ther; 2007 Aug 03; 29(8):1784-94. PubMed ID: 17919559
    [Abstract] [Full Text] [Related]

  • 25. Financial Strain and Medication Adherence among Diabetes Patients in an Integrated Health Care Delivery System: The Diabetes Study of Northern California (DISTANCE).
    Lyles CR, Seligman HK, Parker MM, Moffet HH, Adler N, Schillinger D, Piette JD, Karter AJ.
    Health Serv Res; 2016 Apr 03; 51(2):610-24. PubMed ID: 26256117
    [Abstract] [Full Text] [Related]

  • 26. Awareness of albuminuria in an Italian population-based cohort of patients treated with hypoglycemic drugs.
    Degli Esposti L, Saragoni S, Buda S, Sturani A, Quintaliani G, Bartolucci S, Di Turi R, Lilli P, Didoni G, Degli Esposti E.
    J Nephrol; 2012 Apr 03; 25(3):325-31. PubMed ID: 21748718
    [Abstract] [Full Text] [Related]

  • 27. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
    Maciejewski ML, Bryson CL, Perkins M, Blough DK, Cunningham FE, Fortney JC, Krein SL, Stroupe KT, Sharp ND, Liu CF.
    Am J Manag Care; 2010 Jan 01; 16(1):e20-34. PubMed ID: 20059288
    [Abstract] [Full Text] [Related]

  • 28. Vascular risk factor awareness before and pharmacological treatment before and after stroke and TIA.
    Nolte CH, Jungehulsing GJ, Rossnagel K, Roll S, Haeusler KG, Reich A, Willich SN, Villringer A, Muller-Nordhorn J.
    Eur J Neurol; 2009 Jun 01; 16(6):678-83. PubMed ID: 19236460
    [Abstract] [Full Text] [Related]

  • 29. Associations between shift work and use of prescribed medications for the treatment of hypertension, diabetes, and dyslipidemia: a prospective cohort study.
    Tucker P, Härmä M, Ojajärvi A, Kivimäki M, Leineweber C, Oksanen T, Salo P, Vahtera J.
    Scand J Work Environ Health; 2019 Sep 01; 45(5):465-474. PubMed ID: 30847495
    [Abstract] [Full Text] [Related]

  • 30. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
    Boero R, Prodi E, Borsa S, Berti V, Fiorio E, Ferraro L, Massara C, Quarello F.
    G Ital Nefrol; 2002 Sep 01; 19(4):413-8. PubMed ID: 12369043
    [Abstract] [Full Text] [Related]

  • 31. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
    Kawecka-Jaszcz K, Jankowski P, Pajak A.
    Int J Cardiol; 2003 Sep 01; 91(1):15-23. PubMed ID: 12957725
    [Abstract] [Full Text] [Related]

  • 32. Early discontinuation: more frequent among general practitioners with high levels of prescribing.
    Hansen DG, Gichangi A, Vach W, Felde LH, Larsen J.
    Eur J Clin Pharmacol; 2007 Sep 01; 63(9):861-5. PubMed ID: 17618428
    [Abstract] [Full Text] [Related]

  • 33. [Potential of combined hypoglycemic, antihypertensive, and hypolipidemic therapy in patients with diabetes mellitus and diabetic foot syndrome].
    Onuchin SG, Elsukova OS, Onuchina EL.
    Klin Med (Mosk); 2008 Sep 01; 86(8):61-6. PubMed ID: 18819351
    [Abstract] [Full Text] [Related]

  • 34. Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom.
    Danese MD, Gleeson M, Griffiths RI, Catterick D, Kutikova L.
    J Med Econ; 2017 Sep 01; 20(9):931-937. PubMed ID: 28635339
    [Abstract] [Full Text] [Related]

  • 35. Discontinuation of blood pressure-lowering, glucose-lowering, and lipid-lowering medications after bariatric surgery in patients with morbid obesity: a nationwide cohort study in South Korea.
    Jeon SM, Kwon Y, Kim D, Hwang J, Heo Y, Park S, Kwon JW.
    Surg Obes Relat Dis; 2024 Sep 01; 20(9):840-848. PubMed ID: 38631926
    [Abstract] [Full Text] [Related]

  • 36. Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India.
    Chugh PK, Gupta P, Wasan H, Tripathi CD, Chandy SJ, Ranjalkar J, Bright HR, Badyal DK, Samuel MP, Jhaj R, Banerjee A, Joshi R, Medhi B, Prakash A, Kamat S, Tripathi R, Shetty Y, Parmar U, Dikshit H, Mishra H, Roy SS, Kumar R, Chatterjee S, Bhattacharya M, Samanta K, Trivedi N, Shah P, Chauhan J, Ramasamy R, Mathaiyan J, Gauthaman J, Kaushal S, Jain S, Arora S, Gupta K, Cherian JJ, Chatterjee NS, Kshirsagar NA.
    Indian J Pharmacol; 2024 Mar 01; 56(2):97-104. PubMed ID: 38687313
    [Abstract] [Full Text] [Related]

  • 37. More Prevalent Prescription of Medicine for Hypertension and Metabolic Syndrome in Males from Couples Undergoing Intracytoplasmic Sperm Injection.
    Elenkov A, Al-Jebari Y, Giwercman A.
    Sci Rep; 2018 Sep 28; 8(1):14521. PubMed ID: 30266963
    [Abstract] [Full Text] [Related]

  • 38. Reductions in medications with substantial weight loss with behavioral intervention.
    Anderson JW, Jhaveri MA.
    Curr Clin Pharmacol; 2010 Nov 28; 5(4):232-8. PubMed ID: 20925648
    [Abstract] [Full Text] [Related]

  • 39. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC, Charlton J, Latinovic R.
    J Hum Hypertens; 2005 Feb 28; 19(2):111-7. PubMed ID: 15361893
    [Abstract] [Full Text] [Related]

  • 40. Medication adherence star ratings measures, health care resource utilization, and cost.
    Poonawalla IB, Chung L, Shetler S, Pearce H, Dixon SW, Racsa P.
    Am J Manag Care; 2024 May 28; 30(5):210-217. PubMed ID: 38748928
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.